-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on UiPath, Lowers Price Target to $15

Benzinga·09/23/2026 13:06:02
UBS analyst Radi Sultan maintains UiPath (NYSE:PATH) with a Neutral and lowers the price target from $19 to $15.